scispace - formally typeset
M

Mark L. Waltzman

Researcher at Boston Children's Hospital

Publications -  29
Citations -  946

Mark L. Waltzman is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Poison control & Medicine. The author has an hindex of 15, co-authored 24 publications receiving 869 citations. Previous affiliations of Mark L. Waltzman include Albert Einstein College of Medicine & Harvard University.

Papers
More filters
Journal ArticleDOI

A randomized clinical trial of the management of esophageal coins in children.

TL;DR: Because 25% to 30% of esophageal coins in children will pass spontaneously without complications, treatment of these patients may reasonably include a period of observation, in the range of 8 to 16 hours, particularly among older children and those with distally located coins.
Journal ArticleDOI

Bispectral index monitoring quantifies depth of sedation during emergency department procedural sedation and analgesia in children.

TL;DR: Bispectral index monitoring correlated with clinical sedation scores and may serve as a useful, objective adjunct in quantifying depth of nondissociative procedural sedation and analgesia in children.
Journal ArticleDOI

The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions

TL;DR: Results indicate that in several cellular environments the bystander effect is dependent on connexin expression and gap junctional communication between HSVtk-positive and HSVdk-negative cells.
Journal ArticleDOI

Veinlite transillumination in the pediatric emergency department: a therapeutic interventional trial.

TL;DR: A benefit in the use of Veinlite transillumination for IV insertion in first attempt and within 2 attempts was indicated, and this technique seemed to facilitate nonemergent IV placement in pediatric patients compared with standard practice.
Journal ArticleDOI

Management of esophageal coins.

TL;DR: Current data support expectant management for a period of 12–24 h with the hope of spontaneous passage and avoidance of general anesthesia and surgical procedure for the symptomatic patient with an esophageal coin.